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T cell activation is restricted in the sense that T cells respond to antigens only
in the context of selfMHC antigens (1) . It has been shown (2-4) thatT cells learn
about self in the thymus but the unanswered question is, how . Approximately 95%
of the cells in the thymus die in situ (5, 6) . To account for the low survival rate,
and forMHC restriction, it has been proposed that themajority of immature thymo-
cytes, whose receptors have little or no affinity for self MHC, do not receive the
proper maturational signals and undergo programmed cell death (7, 8) . Cells that
are strongly self-reactiveare deleted (9-12). The small proportion ofthymocytes whose
receptors have the "right" affinity (low but real) for selfMHC antigens are positively
selected to surviveand are exported to the periphery. These cells wouldbind weakly
to self alone, but they might bind strongly, that is, with activating affinity, to self
plus antigenic peptides (13) . This model predicts that all mature T cells should be
able to recognize the selecting self-MHC molecules . However, the bindingofTcells
with cells bearing selfMHC in theabsence of specific antigen cannot, by definition,
result in activation . With this limitation in mind can we determine if selfrecognition
exists?
After binding to its specific target, an allospecific cytotoxic T cell becomes acti-
vated and kills the target . If this same CTL were also able to bind to a cell bearing
syngeneic MHC antigens, lysis would not be observed because such an interaction
would be of toolow affinity to result in activation . However, Lanzavecchia has shown
that once activated, cytotoxic T cells can kill any target to which they bind or by
whichthey are bound (14) . Basedon the proposition that all matureT cells including
CTL have been selected for low but positive affinity for self, an assay system has
been developed to examine whether cloned allospecific CTL, after activation, can
kill cells bearing syngeneic, but -not third-partyMHC antigens . The resultsofthese
investigations provide the first clear demonstration thatCTLhave detectable affinity
for self MHC and support the positive selection model of T cell maturation .
Materials and Methods
Animals.
￿
CBA/J, C57B1/6J, B10.D2, B10.BR, A/J, C3H.OH, and BALB/cBy mice pur-
chased from The Jackson Laboratories (Bar Harbor, ME) were used as spleen donors .
Tissue Culture Medium.
￿
RPMI 1640medium supplemented with 517o heat-inactivated FCS,
50 Rg/ml gentamycin, 2MM r.-glutamine, and50AM 2-ME, wasused as tissue culture medium
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TABLE I
Target and Effector Cells Used in this Study
* CTL are grouped according to the cloning from which they were obtained.
1 Clones were a generous gift of Dr. Joseph Portanova, Denver, CO .
(TCM).' Cell-free supernatants from 24-h Con A-stimulated rat spleen cell cultures (CAS),
containing 20 mM a-methyl mannoside, were used as a source of IL-2 .
Cells.
￿
Mice were killed by cervical dislocation. Spleenswere obtained under aseptic con-
ditions and single-cell suspensions prepared by gently pressing these organs through wire
mesh screens. Murine and human tumor cell lineswere used as targets in chromium release
assays (Table I).
Con A-stimulated T Cell Blasts.
￿
Con A blasts were prepared by incubating 30 x 106 spleen
cells in 10 ml TCM containing 2.5 Ftg/ml Con A (Type IV; SigmaChemical Co., St. Louis)
at 37°C for 72 h. Viable cells isolated by Ficoll-Hypaque density gradient centrifugation
were propagated for an additional 10 d in TCM containing 20% CAS before their use as
targets in ''Cr-release assays.
LPS-stimulated B Cell Blasts.
￿
LPS blasts were prepared by incubating 30 x 10' spleen cells
in 10 ml TCM containing 25 /Ag/ml LPS (Salmonella typhimurium ; RIBI ImmunoChem Re-
search, Inc., Hamilton, MT) and 20 lag/ml dextran sulfate (500,000 mol wt, 177o sulfate;
PharmaciaFine Chemicals, Uppsala, Sweden) at 37'C for 72 h. Viable cellsisolated by Ficoll-
Hypaque density-gradient centrifugation were resuspended in 5 ml TCM and layered over
5 ml of 50% isotonic Percoll (Pharmacia Fine Chemicals) in 17 x 100 mm Falcon tubes.
After centrifugation (750 g, 20 min, 22'C), the B cell blasts were carefully removed from
theTCM-Percoll interface usinga Pasteurpipette. Thecells were washed once and resuspended
in TCM for "Cr labeling.
CTL Clones.
￿
Responder spleen cells (8 x 106) and mitomycin C-treated allogeneic stimu-
lator spleen cells (2 x 106) were cultured together in 24-well tissue culture plates in 2 ml of
TCM perwell. After 7 d, CTL were harvested by Ficoll-Hypaque density gradient centrifu-
gation. Lymphoblasts (106) were restimulated with mitomycin C-treated allogeneic spleen
' Abbreviations used in this paper: CAS, Con A-stimulated rat spleen cell cultures; TCM, tissue culture
medium.
Cell Name MHC Origin
Targets EL-4 H-2'' C57B1/6 T cell lymphoma
CTLL-2 H-2'' C57B1/6 T cell
TIMIA H-2'' C57B1/6 thymoma
P815 H-2" DBA/2 mastocytoma
S49.1 H-2" BALB/c thymoma
WEHI 7.1 H-2" BALB/c thymoma
A20 H-2" BALB/c B cell lymphoma
PSW H-2`1 BALB/c lymphoma
BW5147.3 H-2k AKR/J thymoma
R1 .1 H-2k C58/J thymoma
C1 .18 .4 H- 2k C3H mycloma
L929 H-2k C3H fibroblast
Raji - Human B cell lymphoma
C'I'L* DAB-1,2,3,6,7,11 H-2`i DBA/2 anti-C57111/6:
DAB-16,17 H-2" BALB/c anti-C57B1/6
KAD-1,2,3,4 H-2k CBA anti-BALB/c
KAD-32 H-2i: CBA anti-BALB/c
BAD-1,2,3.4,5 H-2'' C57B1/6 anti-BALB/c
BAD-61 H-2'' C57B1/6 anti-BALB/ccells (10?) in 10 ml of TCM per 25-cmz Falcon flask. After four rounds of weekly restimula-
tion in the absence of added IL-2, viable CTL were cloned by limiting dilution in TCM
containing 20% CAS and allogeneic spleen cells in 96-well flat-bottomed microtiter plates
afterthe method of Glasebrook andFitch(15). The clones thereby obtained were maintained
by weekly stimulation with mitomycin C-treated allogeneic spleen cells in TCM containing
20% CAS; these clones do not replicate with IL-2 alonebut must be propagated in the pres-
ence of the appropriate allostimulators. CTL clones were given the following designations
based on their allospecificities: DAB (H-2d anti-H-2b); KAD (H-2k anti-H-2d); and BAD
(H-2b anti-H-2d) (Table 1). CTL were used in cytotoxic assays on days 7, 8, and 9 after stim-
ulation.
"Cr Labeling of Target Cells.
￿
Cells to be used as targets in "Cr-release assays were sus-
pended at 1-5 x 106 in 100 /Al of RPMI 1640 medium containing 5% FCS to which 100
/Xi of "Cr (sodium chromate; ICN Radiochemicals, Irvine, CA) were added. The cells were
then incubated for 90 min at 37°C, washed three times in RPMI 1640, and diluted in TCM
for use.
"Cr-release Assays.
￿
The experimental design and details of the three killing assays used
in this investigation are shown in Fig. 1 and are discussed in the Results. In brief, "Cr-
labeled target cells (5 x 103 cells in 50 pl TCM) were placed in individual wells of 96-well
round-bottomed microtiter plates that contained either 50 pl TCM (direct killing assay),
unlabeled stimulator cells (104) in 50 pl TCM (bystander killing assay), or Con A (20 Ag/ml)
in 50 1AI TCM (lectin-mediated killing assay). 2 x 104 CTL in 100 td TCM were immedi-
atelyadded, the plates were centrifuged (50g for 5min) to establishcell contact andincubated
at 37°C. After 6 h of incubation, the plates were centrifuged at 200 g for 10 min and 100
pl ofcell-free supernatant were collected from each well. Radioactivitiesin supernatants were
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FIGURE 1 .
￿
Experimental design. In the direct killing assay, 2 x 104 allospecific cloned CTL
were incubated with 5 x 103 5'Cr-labeled target cells of various MHC haplotypes. In the by-
stander killing assay, 104unlabeled target cells bearingthe activating alloantigens were included
with the CTL and SICr-labeled targets. The lectin-mediated killing assay was identical to the
direct killing assaywith the addition ofCon Ato a finalconcentration of 5 /~g/ml .Specific lysis
was measured after 6 h of incubation.62
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measured in a gamma counter. Percent specific lysis was calculated by the following formula:
percent specific lysis = 100 x [(cpme,, - cpmspot)/(cpmmax - cpm5,1)]. Maximal release
(cpmmax) was determined from supernatants of cells subjected to detergent lysis with 0.5%
Triton X-100. Spontaneous release (cpmspo"t) was determined from target cells incubated
without added CTL.
Statistical Methods.
￿
Results are presented as the means t SD for duplicate determina-
tions. For significance determinations in the bystander killing assays, percent specific lysis
values obtained in bystander and direct killing assays for a given "Cr-labeled target/CTL
combination were compared using the Student's t test.
Results
Experimental Design.
￿
The experimental design for examining whether activated
CTL can recognize and kill cells bearing self MHC antigens is shown in Fig. 1.
Three types ofcytotoxic assays were used. These were termed : (a) direct killing assay;
(b) bystander killing assay; and (c) lectin-mediated killing assay. In the direct killing
assay, the CTL are exposed to a single, chromium-labeled target; effector/target cell
interactions that do not lead to activation of the CTL do not lead to cytolysis. In
the bystander killing assay unlabeled "stimulator" cells bearing the appropriate al-
logeneic MHC antigens are used to activate the CTL, and "Cr-labeled target cells
to detect cytotoxicity. If Lanzavecchia (14) is correct, activated CTL should kill any
"Cr-labeled target cell to which they can bind. If activated CTL have sufficient
binding affinity for self then chromium-labeled target cells bearing syngeneic but
not "third-party" MHC antigens will be killed as bystanders. To show that failure
of activated CTL to kill third-party bystander targets was due to a lack of recogni-
tion rather than resistance to lysis, the lectin-mediated killing assay was used. In
this assay, Con A provides the activating signal and the "glue" allowing the CTL
to bind and kill any target independent of MHC recognition (16).
Bystander Killing of Target Cells Bearing Syngeneic but not Third-Party MHC Antigens by
Activated CTL. In a typical experiment, the CTL clone DAB-3 (H-2d anti-H-2')
was used in the three killing assays described above with "Cr-labeled cells of H-2b,
H-2d, H-2k and human origin (Table II). As predicted by their specificity, DAB-3
killed only H-2b target cells in the direct killing assay; H-2d (syngeneic) and H-2k
or human (third-party) targets were not lysed. In contrast, if unlabeled EL-4 (H-2b)
cells were included in the assay to act as "stimulator" cells then bystander killing
of chromium-labeled target cells bearing H-2d but not third-party MHC antigens
was observed (Table II, underscored data). Although used as controls in the bystander
killing assay, "Cr-labeled EL-4 and CTLL-2 are killed directly, and not as
bystanders, because they bear the allelic MHC antigens (H-2b) for which DAB-3
are specific. All of the target cells were killed in the presence of Con A, indicating
that the inability of "activated" CTL to kill third-party targets in the bystander killing
assay was not due to an inherent resistance to lysis.
To test whether bystander killing of syngeneic target cells was a general character-
istic of activated CTL, the three killing assays were performed using 19 cytotoxic
T cell clones from 6 independent clonings and a variety of chromium-labeled targets.
Each of the assays was performed at least twice with all of the CTL-target cell com-
binations and in any given experiment at least six different CTL clones and eight
targets were used in all three assays. The various CTL clones killed only their al-
lospecific targets in the direct killing assay (data not shown). Representative resultsDUKE
TABLE 11
Bystander Killing of Target Cells Bearing Syngeneic (H-2d)
but not Third-party MHC Antigens by DAB-3, an
H-2d anti-H-26-specific CTL Clone
Unlabeled EL-4 (H-2') were used to activate DAB-3 in the bystander killing
assay.
1 Although used as controls in the bystander killing assay, these targets, being
H-2t', are being killed directly by DAB-3 .
4 Statistically significant values (p < 0.01) comparing specific lysis for each tar-
get in bystander vs. direct killing assays are underscored.
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from bystander killing assays are shown in Table III. In the presence of unlabeled
stimulator cells bearing allospecific MHC antigens (EL-4 [H-2b] for DAB [d anti-b]
clones; P815 [H-2d] for KAD [k anti-d] and BAD [b anti-d] clones), all ofthe clones
tested killed "Cr-labeled target cells bearing MHC antigens syngeneic to the CTL
(underscored data). Third-partytarget cells, bearing neither syngeneic nor allospecific
MHC antigens, were notkilled as bystanders by the activatedCTL. Inlectin-mediated
killing assays, all target cell lines were killed by all T cell clones (data not shown).
To show that syngeneic bystander killing was restricted to recognition of MHC-
encoded molecules, LPS-stimulated spleen cell blasts derived from MHC-congenic
mice were used as chromium-labeled target cells in specific and bystander killing
assays. A representativeexperiment is shown inTable IV. Both direct and bystander
killing of"Cr-labeled LPS blasts were MHC restricted. For example, in the direct
killing assay mediated by the CTL clone DAB-16 (d anti-b), only blasts bearing
H-2b, the allospecific MHC antigens, were killed. In the bystander assay, this same
clone killed chromium-labeled LPS blasts derived from C57B1/6 (allospecific, H-2b,
54°Jo lysis) and B10.D2 (syngeneic, H-2d, 57 ° Jo lysis) mice; nonsignificant bystander
killing (7% lysis) of LPS blasts derived from B10.BR (H-2k) mice was observed.
Thus, as was found with the tumor cell targets (Tables II and III), bystanderkilling
of MHC-congenic LPS blasts was restricted to those bearing MHC antigens syn-
geneic to the individual CTL clones tested.
FineSpecificity ofSyngeneicBystanderKilling. Antigen-specific as well as alloreactive
CTL clones are highly specific and have been shown to be directed against a single
MHC determinant, eg., H-2D, H-2K, or H-2L (17-19). Our results using target
cells derived from MHC-congenic mice showed that syngeneic bystander killing is
restricted to recognition ofMHC-encoded molecules but failed to establish the fine
;''rr-la'xled
target MHC
Direct
killing assay
Percent specific
Bystander'
killing assay
lysis in:
Lectin-mediated
killing assay
EL-4 H-21' 82 ± 4 82 ± 31 52 ± 6
CTLI-2 H-21' 82 ± 1 80 ± 81 29 f 1
P815 H-2" 0 f 0 36 + 0S 58 ± 3
A20 H-2d 0 ± 1 54 + 0 35 ± 1
549.1 H-2`1 0 + 3 36 + 2 34 + 3
BW5147.3 H-2' 0 + 1 5 + 0 65 + 3
L929 H-2k 0 ± 4 0 ± 1 29 ± 5
Raji Human 0 ± 0 0 t 0 42 ± 564
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TABLE III
Bystander Killing of Target Cells Bearing Syngeneic but not Third-party
MHCAntigens by a Variety of CTL Clones
* For the bystander killing assays, unlabeled EL-4 were used to activate the DAB clones; unla-
beled P815 were used to activate the KAD clones.
" Not determined.
4 Statistically significant values (p < 0.02) comparing specific lysis for each target-CTL com-
bination in bystander vs. direct killing assays are underscored.
specificity ofthis self recognition. Therefore, cells derived from MHC-recombinant
animals were used as targets to determine the fine specificity of Syngeneic bystander
killing(Table V). Four of five DBA/2 anti-C57131/6 (d anti-b) CTL clones killed P815
(Kd/Dd/Ld) and C314 .014-derived targets (Kd/Dk) but not A/J-derived targets (Kk/
Dd/Ld) or RU (Kk/Dk). Thus, the fine specificity of syngeneic bystander killing
TABLE IV
Both Direct and Bystander Killing are MHC Restricted
* For bystander killing, unlabeled EL-4 were used to activate DAB-11 and DAB-16 and unla-
beled P815 were used to activate BAD-61 and KAD-32 .
$ Statistically significant values (p < 0 .05) comparing specific lysis for each target-CTL com-
bination in bystander vs. direct killing assays are underscored.
''Cr-labeled
target MHC
Percent
DAB-clones
(d
1 2 3 6
specific lysis in
anti-b)
7 11 16
a bystander* killing
KAD-clones
(k anti-d)
17 1 2 3 4 32
assay
1
(b
2
mediated
BAD-clones
3
anti-d)
4
by :
5 61
EL-4 b 75 80 82 88 84 86 88 80 2 0 0 0 0 27 12 17 32 31 _37
CTLL-2 b 63 77 80 75 54 75 41 -1 0 0 3 6 - - - - - - -
TIMI.4 b 64 80 72 80 - 81 - - 3 14 7 0 - - - - - - -
P815 d 50 48 36 34 73 57 35 72 64 77 72 72 54 63 35 54 89 88 92
A20 d 43 59 54 31 56 26 - 42 96 90 91 94 - - - - - - -
S49.1 d 59 50 36 52 44 37 28 59 70 45 69 45 - - - - - - -
WEHI 7 .1 d 63 50 53 79 - 58 26 - 84 92 77 83 - - - - - - -
PSW d 75 74 73 79 63 57 - - 59 79 75 71 - - - - - - -
BW5147 .3 k 19 16 5 8 12 14 12 0 21 26 21 26 - - - - - - -
L929 k 0 5 0 1 0 0 3 1 16 18 19 21 - - - - - - -
C1 .184 k 0 5 2 0 - 0 - - 48 46 38 30 - - - - - - -
R1 .1 k - - - 5 - - - - - - - - 36 4 0 1 10 0 2
Raji human 0 0 0 0 0 2 0 0 2 2 3 1 - - - - - - -
5'Cr-labeled
target Killing assay DAB-11
Percent specific
DAB-16
lysis induced
BAD-61
by .
KAD-32
B6 blasts Direct 46 ± 1 54 ± 4 10 ± 0 8 ± 4
(H-26) Bystander* 58 ± 13 52 ± 2 39 ± 91 11 ± 1
Lectin-mediated 51 ± 4 67 ± 2 57 ± 4 82 ± 22
B10.132 blasts Direct 0 ± 1 8 ± 2 74 ± 24 100 ± 27
(H-2d) Bystander 57 ± 3 57 ± 12 91 ± 8 100 ± 4
Lectin-mediated 42 t 1 51 t 9 100 ± 27 71 ± 9
B10.BR blasts Direct 15 ± 3 1 ± 0 0 ± 1 11 ± 0
(H-2k) Bystander 13 ± 2 7 ± 2 13 t 6 33 ± 5
Lectin-mediated 47 ± 10 56 ± 5 56 ± 2 47 ± 6' Unlabeled EL-4 were used as stimulator cells.
DUKE
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TABLE V
Fine Specificity of Syngeneic Bystander Killing
Unlabeled EL-4 cells were used as stimulators in bystander killing assays.
1 DAB-l, 2, 3, 6, and 11 are of DBA/2 origin; DAB-17 is of BALB/c origin.
9 Statistically significant values (Exp. 1, p G 0.05 ; Exp. 2, p G 0.01) comparing specific lysis
for each target-CTL combination in bystander vs. direct killing assays are underscored.
mediated by these four clones, DAB-1, 2, 6, and 11 is H-2Kd. Using the same anal-
ysis the fine specificity ofselfrecognition bythe single BALB/c anti-C57B1/6 (d anti-b)
clone tested (DAB-17) was determined to be H-2Dd/Ld. Ofinterest, the remaining
CTL clone DAB-3 (DBA anti-C57131/6) killed cells bearing either H-2K' or H-2D'/
Ld as syngeneic bystanders.
Cloned CTL Are Not Susceptible to Syngeneic Bystander Killing .
￿
Activated CTL can
recognize and kill target cells bearing syngeneic MHC antigens; however, CTL them-
selves bear selfMHC antigens and should be killed as bystanders. Ifthis were true,
how could CTL be propagated in vitro ifeach time they were stimulated they killed
one another? To address this paradox, CTL clones were used as target cells in by-
stander killingassays (Table VI). Syngeneictumor celltargetswere killed as bystanders;
TABLE VI
Cloned CTL Are Not Susceptible to Syngeneic Bystander Killing
Exp . S 'Cr-labeled target
H-2
K I
phenotype
D/L
Percent
killing
1 2
specific lysis in bystander`
mediated by DAB-clones
(d anti-b)t
3 6 11 17
1 P815 d - d _349 32 44 38 37 29
C3H.OH LPS blasts d d k 32 32 37 30 31 10
A/J LPS blasts k k d 0 5 22 8 0 39
Rl .I k - k 7 12 9 11 9 9
2 WEHI 7.1 d - d 43 47 38 36 45 50
P815 d - d 60 64 53 60 58 32
C3H .OH Con A blasts d - k 50 51 46 39 48 4
A/J Con A blasts k - d 2 5 38 7 2 45
YAC-1 k - d 0 10 41 10 1 53
R1 .1 k - k 6 3 2 1 7 8
Fine specificity of bystander killing K`{ Kd d Kd Kd Dd/L`{
Exp. Group
5'Cr-labeled
target
Percent specific lysis in
bystander" killing
mediated by:
DAB-2 DAB-6
1 A EL-4 (H-26) 80 ± 12 88 ± 4
B P815 (H-2d) 48 ± 0 54 ± 3
C DAB-6 (H-2d) 0 t 1 0 ± 0
D BW5147.3 (H-2k) 16 ± 1 8 ± 4
2 E TIMIA (H-26) 80 ± 1 80 ± 3
F A20 (H-2d) 45 ± 6 52 ± 1
G DAB-2 (H-2d) 0 t 1 0 t 1
H C 1 .18.4 (H-2k) 5 ± 1 0 t 266
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however, DAB-2 and DAB-6 CTL clones were not (compare groups B and C and
groups F and G). Similar results have been found for other CTL clones (data not
shown).
Discussion
When a developing T lymphocyte rearranges its a and (3 antigen receptor genes,
the process, it is assumed, is random and the two loci are rearranged independently.
If this is true, then thymocytes must develop that bear all the receptors available
to the individual. The environment places two constraints on the ultimate reper-
toire of the mature T lymphocytes: no cells should be strongly self-reactive while
most or all cells should be self-restricted. These requirements can be met in the con-
text of a model that deals with the affinity of binding of a T cell's receptor to "self"
within the thymus. If, according to this model, an immature thymocyte binds a struc-
ture (usually MHC) on the surface of a bone marrow-derived cell (10, 20) with high
affinity, the thymocyte is aborted . "High affinity" here is a purely operational term,
meaning in the same range as would activate a mature T cell. Abortion ofhigh affinity,
self-reactive T cells assures that T cell autoreactivity is a rare event. Another way
of putting this is that "negative" selection is very efficient, and there is experimental
evidence to support that idea (9-12).
If receptors are randomly generated, and because somatic mutation of expressed
receptors does not seem to occur (21, 22), the majority of developing thymocytes
will have virtually no affinity for the MHC of the thymus they find themselves in.
According to the model, these cells are neither positively nor negatively selected,
and die in situ, their death being programmed (7, 8, 10). But a small proportion
of thymocytes will have affinity for self-MHC that is too low to activate a T cell,
but that could, for example, allow transient binding to a thymic epithelial cell and
reception of a trophic signal from it. This signal would trigger maturational events
such as acquisition of homing markers (23), glucocorticoid resistance (24), loss of
CD4 or CD8 (25, 26), and export to the periphery. "Positive" selection for T cells
with low affinity for self-MHC leads to self restriction in that these cells may have
high affinity for self plus foreign antigens (2, 3, 13).
A prediction of the self-recognition model of T cell maturation, or positive-selection
model as it has also been called, is that all mature T cells will have affinity for the
self-MHC molecules used for selection; however, this affinity will not be high enough
to activate the T cell and the interaction will be difficult to observe. The present
studies were based on the notion that low affinity interactions between T cells and
other cells bearing syngeneic MHC molecules could be observed if the T cells were
first activated. The rationale for this idea was as follows. Antigen-driven T cell acti-
vation can be readily detected in vitro by assays that measure proliferation or acqui-
sition of an effector function, e.g., lymphokine production or cytotoxicity. Self rec-
ognition by T cells cannot result in activation, and this binding, if it exists, cannot
be detected by these conventional assays. Lanzavecchia has shown that once acti-
vated, CTL can kill any cell to which they are bound (14). Therefore, an assay system
was developed to test the idea that activated allospecific CTL clones, by virtue of
their ability to recognize self, could kill bystander cells bearing syngeneic but not
third-party MHC antigens . This was found to be the case, and the results lend sup-
port to the self-recognition model of T cell repertoire selection .DUKE
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Alloreactive CTL clones were used in killing assays on days 7-9 after restimula-
tion with allogeneic spleen cells, a time at which they were likely to be in an inacti-
vated or resting condition (27). When mixed with "Cr-labeled targets alone in the
"direct" killing assay, the CTL clones killed only their allospecific targets; any inter-
actions withtarget cells bearing syngeneic or third-party MHC antigens must have
been below the threshold ofactivation required to elicit CTL effector function (13).
However, after activation of the CTL by unlabeled allospecific target cells, the un-
derlying ability ofthese effector T cells to recognize and bind to cells bearing self-
MHC antigens was revealed in the "bystander" killing assay (Tables II-IV). The
capacity of activated CTL clones to recognize self and not third-party MHC an-
tigens was absolute in this relatively small sample; when activated, none of the 19
clones failed to kill syngeneic bystander targets and likewise no clones were found
that killed bystanders bearing third-party MHC antigens (Table III). The failure
ofactivated clones to kill third-party bystander targets was likely due to lack ofrec-
ognition of third-party MHC antigens; all of the clones were able to kill all of the
various targets in the presence of Con A (Tables II, IV, and data not shown).
As hasbeen shown for antigen-specifickilling(17-19), syngeneic bystanderkilling
is restricted to a single MHC determinant; self-recognition by 5 of6 H-2d anti-H-26
CTL clones tested was found to be restricted to either H-2Kd or H-2Dd/Ld but not
both (Table V). This result provides the strongest support for the positive selection
model ofTcell maturation in that mostTcells with "low but real"affinity for self-H-
2K would not be expected to also have this "right" affinity forself-H-2D/L. It is rea-
sonable to assume, therefore, that DAB-3, theonly clone tested that killed bystander
targets bearing H-2Kd or H-2Dd/Ld, is coincidentally crossreactive or is not a true
clone. Subcloning ofDAB-3 is currently being done in order to distinguish between
these possibilities.
Further experiments are in progress to determine whether selfrecognition in the
absence of specific antigen is characteristic of all T cells. Our results clearly show
that activated CTL can recognize, bind, and kill bystander target cells bearing syn-
geneic MHC antigens, confirming the prediction ofthe self-recognition model that
mature T cells should have low but detectable affinity for the self-MHC molecule
used for their selection. In conjunction with the recent reports from several groups
studying Tcell development in vivo (12, 28-30), the present findings provide strong
support for themodel itself; that Tcell repertoire selection isdirected by self-MHC,
or more concisely, by the ability ofa small number ofT cell precursors to recognize
self-MHC antigens in the thymus allowing them to be positively selected to survive
and mature (2-4).
Several additional points concerning syngeneic bystander killing should be con-
sidered. Ifsyngeneic bystander killing also occurs in vivo, two potential problems
need to be addressed. First, since CTL bear MHC antigens shouldn't they kill one
another once activated? Second, in a virally infected tissue, for example, shouldn't
uninfected cells bekilled by MHC-restricted, virus-specific CTL?The data presented
in Table VI address the first question and show that CTL are themselves resistant
to syngeneic bystanderkilling. Consistent with this observation, several investigators
have found that CTL clones are resistant to CTL-mediated cytolysis (31-33) and
so the lack ofkilling of cloned CTL as bystander targets is probably not due to a
lack ofrecognition by the activated CTL, but to relative resistance to killing. The68
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second question wasnotdirectly investigated. However, "innocentbystander" damage
often occurs in tissues during immune responses in vivo, and while this damage is
usually attributed to nonspecific phagocytes recruited to the site of inflammation,
there is no evidence to refute the idea that some immunopathology may be due to
syngeneic bystander killing by CTL. In addition, preliminary results suggest that
CTL are able to killbystanders onlyfor a shorttime afteractivation (datanot shown),
and perhaps, as suggested by Lanzavecchia (14), only when a three-cell conjugate
of CTL, specific target, and syngeneic target exists. Thus the in vitro conditions
used to demonstrate bystander killing favor rapid and preferential formation ofthe
appropriate conjugates, whereas in vivo such conditions may not exist.
Bystanderkilling by activated CTLclones hasbeen observedby a number ofgroups
(34-37); however, a preference for bystander targets bearing MHC antigens syn-
geneic to the effector cell has not been noted. In many of these studies the CTL
were activated by much moreextremeprotocols thanthose used inthe presentstudy.
Thus, bystander killing has been observed when the effector cells are activated by
extensive crosslinking of the CTL receptor with specific antibodies (34, 35), or by
calcium ionophores and phorbol esters (36, 37). Because these protocols may lead
to increased conjugate formation or unusually prolonged activation, it is difficult
to establish their bearing on the results presented here. With regards to bystander
killing it is important tonotethat selfrecognition was not observedby Lanzavecchia
in his "backwards" killing experiments (14), which formed the basis for the present
syngeneic bystander killing assay. In his study, a single syngeneic bystander target
was tested, this being a Th clone syngeneic to the CTL and which, like the CTL,
boundto and was activated by the unlabeled stimulator cell. Whereas a third-party
Th clone that bound directly to the CTL was killed as a bystander, the syngeneic
Th clonewas not. Thecomplexityofthis system makesinterpretation difficult; how-
ever, Lanzavecchia remarks that Th clones are poor "stimulators" and therefore it
is also possible that they are poor syngeneic bystandertargets. This question is cur-
rently under investigation.
A final reference should be made concerning the observations that T cells do not
respond to intact antigens but to antigenic peptide fragments bound within a cleft
ofthe self-MHC molecules on APCs (38-40). In terms ofthe self-recognition model
presented above, this finding would suggest that T cells are positively selected not
by self-MHC alone but by self-MHC plus some self-peptide. If T cell repertoire
selection is based on low affinityfor self-MHC plus a self-peptide chosen at random,
then the strict self recognition by activated CTL might be explained by one of the
following. First, the target cells chosen for this experiment must present several self-
peptides in the context of self-MHC including those used for positive selection of
the CTL clones themselves during their maturation in the thymus. The possibility
then exists that a target cell could be found that is not susceptible to syngeneic by-
stander killing because it does not bear the particular self-peptide. Second, as sug-
gested by a model of positive selection in a recent review by Fink (41), the number
ofself-peptides used for selection may be quitelimited and these are perhapspresented
by all cells. This would explain why syngeneic bystander killing was observed in
everyCTL-bystander combination tested. Third, it is possible that selection occurs
based on recognition of polymorphic determinants common to self-MHC regard-
less ofthe peptidebound, an idea consistent with the recent findings ofMacDonaldDUKE
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et al. (28). This last explanation seems to be the most satisfactory as it is difficult
to understand how strict self-MHC-restriction could result from selection based in
part on randomly chosen self-peptides. Experiments are in progress to elucidate these
possibilities .
Summary
Activated CTL can kill any cell to which they bind or by which they are bound.
This observation has been used to determine whether alloreactive CTL can recog-
nize cells bearing self-MHC. When activated by their specific targets, 19 CTL clones
of 4 different specificities and origins killed bystander targets bearing syngeneic but
not third-party MHC antigens. Using target cells derived from MHC-recombinant
animals, syngeneic bystander killing was shown to be restricted to a single self MHC-
encoded molecule. These results provide the first clear demonstration that T cells,
or more precisely CTL, are capable of selfrecognition in the absence oftheir specific
antigen . Our findings support the model that T cell repertoire selection occurs as
a result of positive selection during maturation in the thymus ofprecursor cellswhose
antigen receptors have low but real affinity for self-MHC.
The author is indebted to Dr. Joseph Portanova for the generous gift of the DBA/2 anti-
C57B1/6 CTL clones that initiated these studies; Drs. John Moorhead, Don Bellgrau, and
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J. John Cohen for his support and for the use of his lab, supplies, and most important, his
pen, without which preparation of this manuscript would have been impossible.
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